HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Cohort
Clinical indicators predict refractory Mycoplasma pneumoniae pneumonia in children
New Tool Predicts Which Kids Need Stronger Pneumonia Treatment
This retrospective case–control analysis evaluated 522 children with Mycoplasma pneumoniae pneumonia (MPP) to identify predictors of refract…
This new model gives doctors a simple way to identify children with pneumonia who might need stronger treatment right away.
Frontiers
Apr 21, 2026
Infectious Disease
Cohort
PBMC gene expression profiles differentiate refractory Mycoplasma pneumoniae pneumonia in children
New Blood Test Distinguishes Severe Lung Infection Early
This cohort study of 349 children identified peripheral blood mononuclear cell gene expression profiles as potential biomarkers for refracto…
A new four-gene blood test helps doctors spot severe, hard-to-treat pneumonia in children before symptoms get too bad to fix easily.
Frontiers
Apr 16, 2026
Pediatrics
Cohort
Retrospective study identifies CRP, pleural effusion, and LDH as risk factors for plastic bronchitis in children with refractory M. pneumoniae pneumonia
Study identifies three risk factors for plastic bronchitis in children with severe pneumonia
A retrospective cohort study of 205 hospitalized children with refractory Mycoplasma pneumoniae pneumonia found that 25.4% (52 patients) dev…
Doctors found three warning signs in children with severe pneumonia that predict a dangerous airway complication called plastic bronchitis.
Frontiers
Apr 4, 2026